| | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $444,629 ) |
| | 2025 | 2025 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 4 | 11/1/2024 | NON-COMPETING CONTINUATION | $444,629 |
|
| Issue Date FY: 2024 ( Subtotal = $465,225 ) |
| | 2024 | 2024 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 3 | 11/15/2023 | NON-COMPETING CONTINUATION | $440,741 |
| | 2024 | 2024 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 3 | 4/17/2024 | NON-COMPETING CONTINUATION | $24,484 |
| | 2024 | 2022 | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY | 3601 SPRUCE ST | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | Cancer Treatment Research | 002 | 1 | 5/2/2024 | NEW | -$86,753 |
| | 2024 | 2022 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 003 | 2 | 5/2/2024 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $86,753 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY | 3601 SPRUCE ST | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | Cancer Treatment Research | 000 | 1 | 8/29/2023 | NEW | -$363,541 |
| | 2023 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 2 | 8/29/2023 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $363,541 |
|
| Issue Date FY: 2022 ( Subtotal = $548,495 ) |
| | 2022 | 2022 | WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, THE | 3601 SPRUCE ST | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | Cancer Treatment Research | 000 | 1 | 7/29/2022 | NEW | $548,495 |
|
|
